Medicaid Rx Spending Up 24% in 2014 With Expanded Eligibility, HCV Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
HCV drugs also contribute to 16.9% surge in Medicare Part D spending in 2014, CMS says in health expenditures review.